Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Terazosin and Parkinson's Disease Extension Study [Phase 2]
This clinical trial update covers a Phase 2 extension study of terazosin for symptomatic Parkinson's disease and REM sleep behavior disorder…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: The Influence of Vibrotactile Stimulation on Self-selected Walking Speed in People With Parkinson's Disease [NA]
ClinicalTrials.gov entry indicates a study on vibrotactile stimulation to influence self-selected walking speed in people with Parkinson's d…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Effects of rTMS on Balance Performance and Functional Mobility in Parkinson's Disease [NA]
A completed clinical trial from Chung Shan Medical University assesses the effects of repetitive transcranial magnetic stimulation (rTMS) on…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: The Role of Priors in Hallucinatory Perception in Parkinson's Disease
This clinical trial update describes a study exploring how prior information influences hallucinatory perception in Parkinson's disease. Rec…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Study To Assess Effectiveness and Adverse Events of Foscarbidopa/ Foslevodopa in Adult Participants With Advanced Parkinson Disease in Real Life Setting
An ongoing real-world clinical trial update evaluating the effectiveness and adverse events of Foscarbidopa/Foslevodopa in adults with advan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Use of CereGate Therapy for Freezing of Gait in PD [NA]
Clinical trial update for CereGate Therapy aimed at treating Freezing of Gait in Parkinson disease; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Identifying the Neural Signature of Exercise to Advance Treatment of PD Cognitive Declines [NA]
The Cleveland Clinic-sponsored clinical trial evaluating the neural signatures of exercise to treat cognitive decline in Parkinson disease h…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach [Phase 3]
Phase 3 multi-centre trial (currently recruiting) evaluating whether pharmacologically modulating the noradrenergic arousal system can reduc…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Efficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care Partners [NA]
This clinical trial update notes a study evaluating SKY breathwork on well-being in individuals with Parkinson's disease and their care part…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease [Phase 2]
A phase 2 clinical trial is testing Dapansutrile, an anti-inflammatory medication, in people with Parkinson disease and is currently recruit…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Turkish Validation and Reliability of the John Hopkins In-Room Independence Scale
Turkish validation and reliability assessment of the John Hopkins In-Room Independence Scale, a tool for measuring functional independence i…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Description of the Reasons for Hospitalization of Patients With Parkinson's Disease Following Admission Through the Adult Emergency Department
This clinical trial update describes the reasons for hospitalization of adults with Parkinson disease after presentation to the adult emerge…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
A recruiting clinical trial called BLAAC PD aims to study connections to Parkinson's disease in Black and African American individuals, spon…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects [NA]
A clinical trial exploring differences in brain metabolite concentrations using 7 Tesla NMR spectroscopy in striatum and subthalamic nuclei …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Cross-sectional Study of Vitamin B6 in Parkinson's Disease
A completed cross-sectional study investigated Vitamin B6 (pyridoxine) in Parkinson's disease, as reported by the University of Rochester.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Effects of Home-based High-speed Bodyweight Resistance Training in Individual With Parkinson's Disease [NA]
A clinical trial evaluating home-based high-speed bodyweight resistance training for individuals with Parkinson's disease is currently recru…
-
EMA approval · 2026-02-25EMA Authorised: DaTSCAN (ioflupane (123l)) — GE Healthcare B.V.
EMA authorised DaTSCAN, a radiopharmaceutical imaging agent (ioflupane I-123) by GE Healthcare B.V., for use in the diagnostic assessment of…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Impact of C-Mill Rehabilitation on the Gut-Brain Axis in Parkinson's Disease [NA]
A clinical trial is evaluating whether C-Mill rehabilitation affects the gut-brain axis in Parkinson's disease. The study is currently recru…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Validation of a Novel Functional Food Designed to Meet the Nutritional Needs of People Living With Parkinson's Disease [NA]
Clinical trial update on validating a novel functional food designed to meet the nutritional needs of people with Parkinson's disease; const…
-
EMA approval · 2026-02-24EMA Authorised: Exelon (rivastigmine) — Novartis Europharm Limited
The European Medicines Agency authorised Exelon (rivastigmine) for dementia including Alzheimer's disease and Parkinson's disease, with Nova…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Predictors of Clinical Outcomes of Deep Brain Stimulation in Parkinson's Disease
A ClinicalTrials.gov entry describes a study investigating predictors of clinical outcomes for deep brain stimulation in Parkinson's disease…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Visuospatial and Affective Abilities in Parkinson Disease [NA]
A clinical trial examining visuospatial and affective abilities in Parkinson disease, including alexithymia, is currently enrolling by invit…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Movement State-dependent Adaptive DBS for PD [NA]
Clinical trial update on movement state-dependent adaptive deep brain stimulation for Parkinson's disease, currently enrolling by invitation…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Pyridostigmine for the Treatment of Constipation in Parkinson Disease [Phase 2]
A Phase 2 clinical trial evaluating pyridostigmine for constipation in Parkinson disease is currently recruiting. The study is led by the Un…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease
A clinical trial is investigating cutaneous phosphorylated alpha-synuclein as a biomarker to identify essential tremor patients who may prog…